BRF - Brasil Foods (NYSE: BRFS) reported earnings on April 27. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended March 31 (Q1), BRF - Brasil Foods missed estimates on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue shrank and GAAP earnings per share contracted significantly.

Margins contracted across the board.

Revenue details
BRF - Brasil Foods tallied revenue of $3.48 billion. The 11 analysts polled by S&P Capital IQ anticipated a top line of $3.58 billion on the same basis. GAAP reported sales were 6.2% lower than the prior-year quarter's $3.70 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.19. The three earnings estimates compiled by S&P Capital IQ predicted $0.15 per share. GAAP EPS of $0.10 for Q1 were 63% lower than the prior-year quarter's $0.27 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 21.2%, 450 basis points worse than the prior-year quarter. Operating margin was 4.1%, 470 basis points worse than the prior-year quarter. Net margin was 2.4%, 400 basis points worse than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $3.64 billion. On the bottom line, the average EPS estimate is $0.10.

Next year's average estimate for revenue is $14.48 billion. The average EPS estimate is $0.92.

Investor sentiment
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 233 members out of 248 rating the stock outperform, and 15 members rating it underperform. Among 64 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 61 give BRF - Brasil Foods a green thumbs-up, and three give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on BRF - Brasil Foods is hold, with an average price target of $22.14.